Thus, in lowering MFN2 expression for AD-N LCLs, prolonged ROS exposure did alter MFN2 toward the baseline expression of the AD-A LCLs, suggesting that this difference in MFN2 expression may be an integral part of the regulation and maintenance of the atypical mitochondrial activity. Here, MFN2 is linked to Alzheimer disease.